AFI 004
Alternative Names: AFI-004Latest Information Update: 28 Aug 2020
Price :
$50 *
At a glance
- Originator Altus Formulation Inc
- Developer Altus Formulation Inc; Unknown
- Class Opioid analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Pain in Canada (PO, Controlled release)
- 28 Aug 2020 No recent reports of development identified for research development in Pain in USA (PO, Controlled release)
- 29 Jul 2016 Early research in Pain in Canada (PO)